文献速递系统性红斑狼疮

系统性红斑狼疮患者疲劳与严重疲劳的预测因素:大型国际队列研究及系统综述

Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究基于德法Lupus BioBank队列570例符合1997年ACR标准的SLE患者,评估疲劳与严重疲劳的决定因素。结果显示67.7%报告疲劳、36.7%报告严重疲劳;多因素分析中疲劳与抑郁、焦虑、糖皮质激素治疗、SELENA-SLEDAI评分及采样年龄相关,严重疲劳与焦虑、抑郁、糖皮质激素治疗及年龄独立相关。

要点

  • SLE患者中疲劳常见(67.7%),严重疲劳亦达36.7%。
  • 抑郁和焦虑与疲劳及严重疲劳均呈强关联。
  • 疾病活动度和糖皮质激素使用与疲劳独立相关但较弱。

核心结论

  • 疲劳和严重疲劳是SLE常见症状,与抑郁和焦虑强相关,疾病活动和糖皮质激素使用亦独立相关但较弱。

研究设计与样本

  • 纳入Lupus BioBank of the upper Rhein德法SLE队列中符合1997年ACR标准且收集了疲劳量表(FSMC)评分的患者,进行多因素logistic回归分析并附系统文献综述。

主要发现

  • 共纳入570例患者(89.1%女性),中位年龄42岁(IQR 34-52),SELENA-SLEDAI中位值2(0-4)。
  • 386例(67.7%)报告疲劳,209例(36.7%)报告严重疲劳。
  • 疲劳与抑郁(OR 4.72,95%CI 1.39-16.05,P=0.01)、焦虑(OR 4.49,95%CI 2.60-7.77,P<0.0001)、糖皮质激素治疗(OR 1.59,95%CI 1.05-2.41,P=0.04)、SELENA-SLEDAI每增加1分(OR 1.05,95%CI 1.00-1.12,P=0.043)及采样年龄每增加1岁(OR 1.01,95%CI 1.00-1.03,P=0.03)相关。
  • 严重疲劳与焦虑(P<0.0001)、抑郁(P<0.0001)、糖皮质激素治疗(P=0.047)及采样年龄(P=0.03)独立相关。

临床怎么用

  • 对SLE患者应筛查抑郁和焦虑,其与疲劳及严重疲劳强相关。
  • 疾病活动和糖皮质激素使用与疲劳独立相关但较弱,控制疾病活动可能部分改善疲劳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fatigue is reported in up to 90% of patients with SLE. This study was conducted to identify the determinants associated with fatigue in a large cohort of patients with SLE, as well as to provide a systematic review of the literature. METHODS: Patients from the Lupus BioBank of the upper Rhein, a large German-French cohort of SLE patients, were included in the FATILUP study if they fulfilled the 1997 ACR criteria for SLE and had Fatigue Scale for Motor and Cognitive Functions scores collected. Multivariate logistic regression analyses were performed to assess the determinants of fatigue and severe fatigue. RESULTS: A total of 570 patients were included (89.1% female). The median age was 42 years (interquartile range 25-75: 34-52). The median value of the SAfety of Estrogens in Lupus Erythematosus National Assessment (SELENA)-SLEDAI was 2 (0-4). Fatigue was reported by 386 patients (67.7%) and severe fatigue by 209 (36.7%). In multivariate analyses, fatigue was associated with depression [odds ratio (OR): 4.72 (95% CI: 1.39-16.05), P = 0.01], anxiety [OR: 4.49 (95% CI: 2.60-7.77), P < 0.0001], glucocorticoid treatment [OR: 1.59 (95% CI 1.05-2.41), P = 0.04], SELENA-SLEDAI scores [OR: 1.05 (95% CI: 1.00-1.12) per 1 point increase, P = 0.043] and age at sampling [OR: 1.01 (95% CI: 1.00-1.03) per 1 year increase, P = 0.03]. Severe fatigue was independently associated with anxiety (P < 0.0001), depression (P < 0.0001), glucocorticoid treatment (P = 0.047) and age at sampling (P = 0.03). CONCLUSION: Both fatigue and severe fatigue are common symptoms in SLE, and are strongly associated with depression and anxiety. Disease activity and the use of glucocorticoids were also independently associated with fatigue, although more weakly.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Arnaud L, Gavand PE, Voll R, et al. Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature. Rheumatology (Oxford). 2019. PMID: 30597077. doi:10.1093/rheumatology/key398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。